Jeffrey M. Leiden, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 26,532 shares at $200.06 ($5.3M) on 2019-11-01, disclosed to the SEC on 2019-11-04.
Open-market sale of $5.3M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |